ENSC Ensysce Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ENSC

Price (delayed)

$0.3018

Market cap

$4.43M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.16

Enterprise value

$3.94M

?
Relative Growth: Rel. Growth: 20
Relative Strength: Rel. Strength: 0
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 0
Highlights
The company's EPS has surged by 53% YoY and by 21% QoQ
Ensysce Biosciences's debt has decreased by 20% from the previous quarter and by 4.5% YoY
The equity has plunged by 111% YoY and by 111% from the previous quarter
ENSC's quick ratio has plunged by 85% YoY and by 75% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of ENSC

ENSC stock price

How has the Ensysce Biosciences stock price performed over time
Intraday
13.89%
1 week
0.27%
1 month
-27.63%
1 year
-87.32%
YTD
-67.2%
QTD
-43.96%

Financial performance

How have Ensysce Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$11.84M
Net income
-$11.79M
Gross margin
N/A
Net margin
N/A
Ensysce Biosciences's operating income has shrunk by 73% YoY and by 16% QoQ
ENSC's net income has dropped by 73% year-on-year and by 16% since the previous quarter

Price vs fundamentals

How does ENSC's price correlate with its fundamentals

Growth

What is Ensysce Biosciences's growth rate over time

Valuation

What is Ensysce Biosciences stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 53% YoY and by 21% QoQ
The equity has plunged by 111% YoY and by 111% from the previous quarter

Efficiency

How efficient is Ensysce Biosciences business performance
The company's return on assets has shrunk by 111% YoY and by 31% QoQ
ENSC's return on equity has dropped by 68% since the previous quarter

Dividends

What is ENSC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ENSC.

Financial health

How did Ensysce Biosciences financials performed over time
Ensysce Biosciences's total assets is 24% lower than its total liabilities
ENSC's quick ratio has plunged by 85% YoY and by 75% from the previous quarter
Ensysce Biosciences's current ratio has shrunk by 72% YoY and by 55% QoQ
Ensysce Biosciences's debt is 172% more than its equity
The equity has plunged by 111% YoY and by 111% from the previous quarter
Ensysce Biosciences's debt has decreased by 20% from the previous quarter and by 4.5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.